Molecular mechanism of inhibition of the abnormal proliferation of human umbilical vein endothelial cells by hydroxysafflor-yellow A

VEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growth

(2015) Xiuli Li et al.   Journal of Translational Medicine

VEGF-B promotes cancer metastasis through a VEGF-A–independent mechanism and serves as a marker of poor prognosis for cancer patients

(2015) Xiaojuan Yang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

VEGFR3 does not sustain retinal angiogenesis without VEGFR2

(2015) Georgia Zarkada et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tumor angiogenesis, from foe to friend

(2015) L. B. Rivera et al.   SCIENCE

Role of the RAS in Pancreatic Cancer

(2011) S. T. Lau et al.   CURRENT CANCER DRUG TARGETS

Differential Regulation of VEGF Signaling by PKC-α and PKC-ε in Endothelial Cells

(2008) Christian Rask-Madsen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Targeting Angiogenesis Driven by Vascular Endothelial Growth Factors Using Antibody-Based Therapies

(2008) Axel Grothey et al.   CANCER JOURNAL

MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell

(2008) J. Xu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE